These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36521783)

  • 1. Risk of anaphylaxis in cluster vs standard subcutaneous multiallergen immunotherapy.
    Chen JH; Orden T; Wang J; Sowho M; Tversky J
    Ann Allergy Asthma Immunol; 2023 May; 130(5):622-627. PubMed ID: 36521783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy.
    Winslow AW; Turbyville JC; Sublett JW; Sublett JL; Pollard SJ
    Ann Allergy Asthma Immunol; 2016 Nov; 117(5):542-545. PubMed ID: 27788885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
    Bernstein DI; Epstein TEG
    Allergy Asthma Proc; 2020 Mar; 41(2):108-111. PubMed ID: 32122446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-year experience of a novel and safe modified environmental rush immunotherapy protocol.
    Fajt ML; Rosenberg SL; Yecies E; Traister RS; Petrov AA
    Allergy Asthma Proc; 2017 Jul; 38(4):309-316. PubMed ID: 28668111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors.
    Rank MA; Oslie CL; Krogman JL; Park MA; Li JT
    Allergy Asthma Proc; 2008; 29(4):400-5. PubMed ID: 18702889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
    Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
    Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of subcutaneous immunotherapy in patients with severe asthma.
    Chow TG; Palka JM; Stone B; Trojan T; Epstein TG; Khan DA
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):585-591.e3. PubMed ID: 35998846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine.
    Phillips JF; Lockey RF; Fox RW; Ledford DK; Glaum MC
    Allergy Asthma Proc; 2011; 32(4):288-94. PubMed ID: 21781404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):274-8, 278.e1. PubMed ID: 23535092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of allergen immunotherapy (IT) in Turkey.
    Dursun AB; Sin BA; Oner F; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(2):123-8. PubMed ID: 16689186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis].
    Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy.
    Dhamija Y; Epstein TEG; Bernstein DI
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):105-119. PubMed ID: 34823741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
    Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM; Kagerer M; Cozzio A; Angelova-Fischer I; Guenova E; Ballmer-Weber B; Hoetzenecker W
    Int Arch Allergy Immunol; 2020; 181(10):783-789. PubMed ID: 32781451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
    Rodríguez Del Río P; Vidal C; Just J; Tabar AI; Sanchez-Machin I; Eberle P; Borja J; Bubel P; Pfaar O; Demoly P; Calderón MA
    Pediatr Allergy Immunol; 2017 Feb; 28(1):60-70. PubMed ID: 27637414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
    Caminati M; Dama AR; Djuric I; Montagni M; Schiappoli M; Ridolo E; Senna G; Canonica GW
    Expert Rev Clin Immunol; 2015 Feb; 11(2):233-45. PubMed ID: 25484197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013).
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):354-359.e2. PubMed ID: 26948485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.
    Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D
    Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.